Showing results (251-260 of 553) with videos related to

Sort By:
Pageof 56
Cancer|June 28, 2012
Number of primary melanomas is an independent predictor of survival in patients with metastatic melanomaRajmohan Murali, Philip T Brown, Richard F Kefford, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1995
Dose-dependent effects of acute in vivo ethanol exposure on extracellular glutamate concentration in the cerebral cortex of the near-term fetal sheepJ D Reynolds, D H Penning, F Dexter, et al.
Immunotherapy|January 30, 2020
Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinomaApoorva Ambavane, Shuo Yang, Michael B Atkins, et al.
BMJ Open Gastroenterology|December 8, 2025
Comparative evaluation of a hybrid machine learning-human adjudication paradigm for endoscopic scoring in ulcerative colitisKlaus T Gottlieb, Chakib Battioui, Yeli Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2010
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinomaDaniel C Cho, Matthew B Cohen, David J Panka, et al.
Melanoma Research|May 5, 2011
Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanomaErin R DeRose, Alexander Pleet, Wei Wang, et al.
Anti-Cancer Drugs|April 22, 1999
Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687)H Hochster, M H Strawderman, J E Harris, et al.
Cancer|March 28, 2006
Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacyKen Wyman, Michael B Atkins, Victor Prieto, et al.
Melanoma Research|December 2, 2021
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitorsCharlene M Mantia, Lillian Werner, Brian Stwalley, et al.
Clinical Genitourinary Cancer|October 23, 2013
Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinomaPeter Beddy, Elizabeth M Genega, Long Ngo, et al.
Pageof 56